The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
216 - Would a RX script pad require PAAB approval? The pad will contain taglines from a PAAB-approved ad. Thank you.
FYI post-approval change/preclearance exemption/what requires review/PAAB scope
1
Posts
1
Posters
297
Views
1
Watching
-
PAAB pre-clearance requirements apply irrespective of the format/media. If it is drug advertising and it is directed to HCPs, it is PAABable. In your case, we would review the tagline in its current context. Note that fair balance requirements would apply. We'd also urge the manufacturer to ensure that distribution of this "Rx script pad" does not contravene the Innovative Medicines Canada code. PAAB does not adjudicate the Innovative Medicines Canada code but we are aware of prior rulings relating to Rx pads.
